Theresa Raimondo is an Assistant Professor of Engineering, with a secondary appointment in the Division of Biology and Medicine.
Dr. Raimondo’s research is broadly focused on the design of targeted drug-delivery vectors and novel RNA-based therapeutics for applications in cancer, immunotherapy, and tissue regeneration. Her research primarily focuses on the development of novel lipid nanoparticles (LNPs) for RNA-based therapies, and her work has contributed to the development of adjuvanted mRNA-based vaccines and siRNA-based cancer immunotherapies. By using engineering approaches to optimize LNP formulation as well as modulating RNA constructs (sequence and chemical modifications), Dr. Raimondo seeks to both better understand how RNA-LNPs modulate immunity and to use this understanding for the development of new therapies.
Dr. Raimondo received her postdoctoral training with Dr. Daniel Anderson and Dr. Robert Langer at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology. She did her graduate work on the development of immune-modulating gold nanoparticles and hydrogels for muscle regeneration with Dr. David Mooney, receiving a Ph.D. in Engineering Sciences – Bioengineering from Harvard University in 2019. She received her Sc.B. in Chemical and Biochemical Engineering from Brown University in 2011. Raimondo has been a recipient of several awards such as a 2022 Convergence Scholar fellowship from MIT’s Marble Center for Cancer Nanomedicine, a National Science Foundation graduate research fellowship, and Harvard’s Smith family graduate fellowship.
